These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18992864)

  • 1. Secreted protein acidic and rich in cysteine as a regulator of murine ovarian cancer growth and chemosensitivity.
    Bull Phelps SL; Carbon J; Miller A; Castro-Rivera E; Arnold S; Brekken RA; Lea JS
    Am J Obstet Gynecol; 2009 Feb; 200(2):180.e1-7. PubMed ID: 18992864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis.
    Said N; Motamed K
    Am J Pathol; 2005 Dec; 167(6):1739-52. PubMed ID: 16314484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer.
    Said N; Najwer I; Motamed K
    Am J Pathol; 2007 Mar; 170(3):1054-63. PubMed ID: 17322388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of the ovarian cancer microenvironment by SPARC.
    Said N; Socha MJ; Olearczyk JJ; Elmarakby AA; Imig JD; Motamed K
    Mol Cancer Res; 2007 Oct; 5(10):1015-30. PubMed ID: 17951402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the ovarian microenvironment on the anti-tumor effect of SPARC on ovarian cancer.
    Greenaway JB; Koehler A; McCulloch CA; Petrik J; Brown TJ; Ringuette MJ
    Biochem Cell Biol; 2012 Feb; 90(1):96-107. PubMed ID: 22003835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in SPARC and VEGF immunoreactivity in epithelial ovarian cancer.
    Paley PJ; Goff BA; Gown AM; Greer BE; Sage EH
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):336-41. PubMed ID: 10985890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved response to nab-paclitaxel compared with cremophor-solubilized paclitaxel is independent of secreted protein acidic and rich in cysteine expression in non-small cell lung cancer.
    Shao H; Tang H; Salavaggione OE; Yu C; Hylander B; Tan W; Repasky E; Adjei AA; Dy GK
    J Thorac Oncol; 2011 Jun; 6(6):998-1005. PubMed ID: 21532503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
    Puolakkainen PA; Brekken RA; Muneer S; Sage EH
    Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-let-7f-1 regulates SPARC mediated cisplatin resistance in medulloblastoma cells.
    Pannuru P; Dontula R; Khan AA; Herbert E; Ozer H; Chetty C; Lakka SS
    Cell Signal; 2014 Oct; 26(10):2193-201. PubMed ID: 25014664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.
    Brown TJ; Shaw PA; Karp X; Huynh MH; Begley H; Ringuette MJ
    Gynecol Oncol; 1999 Oct; 75(1):25-33. PubMed ID: 10502421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells.
    Mok SC; Chan WY; Wong KK; Muto MG; Berkowitz RS
    Oncogene; 1996 May; 12(9):1895-901. PubMed ID: 8649850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer.
    Chen J; Wang M; Xi B; Xue J; He D; Zhang J; Zhao Y
    PLoS One; 2012; 7(8):e42413. PubMed ID: 22879971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.
    Chlenski A; Liu S; Guerrero LJ; Yang Q; Tian Y; Salwen HR; Zage P; Cohn SL
    Int J Cancer; 2006 Jan; 118(2):310-6. PubMed ID: 16052522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
    Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
    J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secreted protein acidic and rich in cysteine antagonizes bufalin-induced apoptosis in gastric cancer cells.
    Li A; Qu X; Li Z; Qu J; Song N; Ma Y; Liu Y
    Mol Med Rep; 2015 Aug; 12(2):2926-32. PubMed ID: 25936899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
    Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy.
    Tai IT; Dai M; Owen DA; Chen LB
    J Clin Invest; 2005 Jun; 115(6):1492-502. PubMed ID: 15902309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC.
    John B; Naczki C; Patel C; Ghoneum A; Qasem S; Salih Z; Said N
    Oncogene; 2019 May; 38(22):4366-4383. PubMed ID: 30765860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of Zengmian Yiliu Recipe combined cisplatin on the tumor inhibition rate in platinum-resistant ovarian cancer].
    Qi C; Zhang QH; Li JX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jun; 32(6):817-21. PubMed ID: 22978111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells.
    Yiu GK; Chan WY; Ng SW; Chan PS; Cheung KK; Berkowitz RS; Mok SC
    Am J Pathol; 2001 Aug; 159(2):609-22. PubMed ID: 11485919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.